For the year ending 2025-12-31, CARL made $50,511K in revenue. -$30,218K in net income. Net profit margin of -59.82%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 50,511 | |||
| Cost of sales | 12,471 | |||
| Gross profit | 38,040 | |||
| Research and development | 17,019 | |||
| Sales and marketing | 35,027 | |||
| General and administrative | 16,568 | |||
| Total operating expenses | 68,614 | |||
| Loss from operations | -30,574 | |||
| Interest expense | 1,430 | |||
| Interest income | 2,698 | |||
| Change in fair value of warrant liabilities | 328 | |||
| Total other income (expense), net | 940 | |||
| Net loss | -29,634 | |||
| Deemed dividend to preferred stockholders | 584 | |||
| Net loss attributable to common stockholders | -30,218 | |||
| Basic EPS | -2.12 | |||
| Diluted EPS | -2.12 | |||
| Basic Average Shares | 14,221,991 | |||
| Diluted Average Shares | 14,221,991 | |||
CARLSMED, INC. (CARL)
CARLSMED, INC. (CARL)